RE:RE:RE:RE:RE:Remember this press release you mean millions I lost millions lol
man you're such a fool. Maybe I didn't even short it. Maybe I was trolling you like you troll the Therma board. But of course you know my account better than I do.
Moe the broke kid who bet it all on Sona and lost. LOL
Moemoney42 wrote: Maybe not the top.. but I know you lost tens of thousands of dollars ($30G, $35G, $40G doesn't matter really) you lost big time and I'm the dumb one...! LOL.. Yup just like always.. when you get exposed for the fool you are you resort to name calling.. the truth hurts eh...
Kaiser wrote: yes I waited till the very top and covered. Lol donkey
man you are one dumb camel jockey. All I can say is Sona Bahahahahhahahah
Moemoney42 wrote: LMAO... ya LAC shorting cost you what.. $40G of lost money... LOL... those $29.32's and $33.90's are still losing shorts.. that you probably covered when LAC spiked to $45 bucks.. LMAO the truth hurts eh.. LOL..
Kaiser wrote: the troll returns. Have balls and short it or return to pumping Sona. Lol!
btw. Lac shorting has been ridiculous. Ouuuuuch! The pump is over. Dump time.
Moemoney42 wrote: "Toronto, Ontario–(Newsfile Corp. – December 7, 2020) – Therma Bright Inc. (TSXV: THRM) (“Therma” or the “Company”), a progressive medical device technology company, is pleased to announce the preliminary results achieved during the feasibility studies indicate a test sensitivity of 80% and a specificity of over 90% for Therma’s CoviSafe™ rapid test for detecting SARS-CoV-2 in saliva
Testing is expected to start before year end, but because of potential delays due to the holidays, may extend into January.
Once testing is complete and a minimum set with 300 samples data will be compiled and sent to both FDA and Health Canada for approval under EUA with FDA and the Interim Order with Health Canada. The Company expects to submit data to both regulatory agencies in early 2021"
So looks like they missed their own self emposed deadlines by a year.. as of this Dec. they might be done field testing for FDA approval.. then maybe the FDA will look at it in the new year if the field data can be replicated.. then on to HC.. more wait time.. no wonder the stock has languished all year.. :-(